Oncotarget

Research Papers:

PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels

Yabing Zheng, Gang Zhao, Bing Xu, Chunyan Liu, Chang Li, Xiaoqian Zhang and Xiaotian Chang _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:62159-62176. https://doi.org/10.18632/oncotarget.11398

Metrics: PDF 1831 views  |   HTML 2339 views  |   ?  


Abstract

Yabing Zheng1,*, Gang Zhao2,*, Bing Xu1, Chunyan Liu1, Chang Li3, Xiaoqian Zhang4, Xiaotian Chang1

1Medical Research Center of Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, P. R. China

2Emergency Surgery Department of Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, P. R. China

3Pathological Department of Tengzhou People’s Central Hospital, Tengzhou, Shandong, P. R. China

4Clinical Laboratory of PKUCare Luzhong Hospital, Zibo, Shandong, P. R. China

*These authors have contributed equally to this work

Correspondence to:

Xiaotian Chang, email: [email protected]

Keywords: peptidyl deiminase (PAD), peptidyl deiminase isoform 4 (PADI4), CXCR2, KRT14, TNF-α

Received: October 18, 2015    Accepted: August 08, 2016    Published: August 19, 2016

ABSTRACT

PADI4 (peptidyl deiminase isoform 4) is overexpressed in many tumor tissues and converts arginine residues to citrulline residues. This study used an Illumina SNP microarray and a TaqMan assay to determine the possible association of the PADI4 gene with various tumor risks. Both genotyping methods demonstrated significant associations between the tag SNPs rs1635566 and rs882537 in the PADI4 locus with gastric carcinoma in two independent cohorts. Based on this genotyping result, we used the Cancer Pathway Finder, p53 Signaling, Signal Transduction and Tumor Metastasis PCR arrays to investigate the tumorigenic pathway of PADI4 in MNK-45 cells derived from gastric carcinoma. We detected significantly decreased expression levels of CXCR2, KRT14 and TNF-α in MNK-45 cells that were treated with anti-PADI4 siRNA. We also detected increased expression of these three genes in MNK-45 cells transfected with a pcDNA3.1 plasmid overexpressing PADI4. A highly similar result was also obtained for SGC 7901 cells, which also originate from gastric carcinoma. Our result indicates that the PADI4 gene has genetic susceptibility in gastric carcinoma. PADI4 contributes to gastric tumorigenesis by upregulating CXCR2, KRT14 and TNF-α expression, which are well known to activate angiogenesis, cell proliferation, cell migration and the immune microenvironment in tumors.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11398